AURA - Aura Biosciences Inc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

332.1M

Cash

173.5M

Avg Qtr Burn

-13.95M

Short % of Float

5.41%

Insider Ownership

8.27%

Institutional Own.

73.87%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Belzupacap Sarotalocan (Bel-sar) Details Primary Choroidal Melanoma	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Belzupacap Sarotalocan (Bel-sar) (Suprachoroidal (SC) Administration) Details Choroidal Metastasis	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Belzupacap Sarotalocan (Bel-sar) Details Non-muscle invasive bladder cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.